Similar articles for PMID: 25190137

Year	Number of Results
2005	4
2006	4
2007	1
2008	1
2009	2
2010	8
2011	8
2012	10
2013	7
2014	10
2015	20
2016	20
2017	10
2018	9
2019	1
2020	1
2021	2
2022	2
2024	0

1

Pharmacotherapy for treatment of retinal vein occlusion.

Sarao V, Bertoli F, Veritti D, Lanzetta P. Sarao V, et al. Expert Opin Pharmacother. 2014 Nov;15(16):2373-84. doi: 10.1517/14656566.2014.956083. Epub 2014 Sep 5. Expert Opin Pharmacother. 2014. PMID: 25190137 Review.

2

Best practices for treatment of retinal vein occlusion.

Hahn P, Fekrat S. Hahn P, et al. Curr Opin Ophthalmol. 2012 May;23(3):175-81. doi: 10.1097/ICU.0b013e3283524148. Curr Opin Ophthalmol. 2012. PMID: 22450223 Review.

3

Comparison between anti-VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta-analysis.

Qian T, Zhao M, Xu X. Qian T, et al. J Clin Pharm Ther. 2017 Oct;42(5):519-529. doi: 10.1111/jcpt.12551. Epub 2017 Jun 22. J Clin Pharm Ther. 2017. PMID: 28639290 Review.

4

Steroids and macular edema from retinal vein occlusion.

Glacet-Bernard A, Coscas G, Zourdani A, Soubrane G, Souied EH. Glacet-Bernard A, et al. Eur J Ophthalmol. 2011;21 Suppl 6:S37-44. doi: 10.5301/EJO.2010.6053. Eur J Ophthalmol. 2011. PMID: 23264327 Review.

5

Macular grid laser photocoagulation for branch retinal vein occlusion.

Lam FC, Chia SN, Lee RM. Lam FC, et al. Cochrane Database Syst Rev. 2015 May 11;2015(5):CD008732. doi: 10.1002/14651858.CD008732.pub2. Cochrane Database Syst Rev. 2015. PMID: 25961835 Free PMC article. Review.

6

Intravitreal steroid and anti-vascular endothelial growth agents for the management of retinal vein occlusion: evidence from randomized trials.

Chatziralli I, Nicholson L, Sivaprasad S, Hykin P. Chatziralli I, et al. Expert Opin Biol Ther. 2015;15(12):1685-97. doi: 10.1517/14712598.2015.1086744. Epub 2015 Sep 11. Expert Opin Biol Ther. 2015. PMID: 26358547 Review.

7

RETINAL VEIN OCCLUSIONS, FROM BASICS TO THE LATEST TREATMENT.

Ho M, Liu DT, Lam DS, Jonas JB. Ho M, et al. Retina. 2016 Mar;36(3):432-48. doi: 10.1097/IAE.0000000000000843. Retina. 2016. PMID: 26716954 Review.

8

A Review of Randomized Trials of Approved Pharmaceutical Agents for Macular Edema Secondary to Retinal Vein Occlusion.

Wang JK. Wang JK. Asia Pac J Ophthalmol (Phila). 2016 Mar-Apr;5(2):159-64. doi: 10.1097/APO.0000000000000168. Asia Pac J Ophthalmol (Phila). 2016. PMID: 26692257 Free article. Review.

9

Antivascular endothelial growth factors in the treatment of macular oedema secondary to central retinal vein occlusion: a meta-analysis.

Zhou S, Gao J, Xu X. Zhou S, et al. Clin Exp Ophthalmol. 2014 Sep-Oct;42(7):637-49. doi: 10.1111/ceo.12286. Epub 2014 Jan 27. Clin Exp Ophthalmol. 2014. PMID: 24330277

10

Reading speed improvements in retinal vein occlusion after ranibizumab treatment.

Suñer IJ, Bressler NM, Varma R, Lee P, Dolan CM, Ward J, Colman S, Rubio RG. Suñer IJ, et al. JAMA Ophthalmol. 2013 Jul;131(7):851-6. doi: 10.1001/jamaophthalmol.2013.114. JAMA Ophthalmol. 2013. PMID: 23699977 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year